Click to learn more about how together we can transform breast screening and advance breast cancer detection for women with dense breast tissue: https://t.co/o4X2rIHiYi.
Delphinus supports International Women's Day, empowering women to make informed health decisions. We're transforming women's health with cutting-edge solutions like the SoftVue™ system, enhancing early cancer detection in women with dense breasts when paired with mammography.
“SoftVue is transforming the screening process and, when combined with mammography, can increase the sensitivity of cancer detection by 25%. Women deserve the best care and earliest diagnosis we can provide.” - Elise Berman, MD
#BreastImaging#DenseBreastAwareness
Under the updated Mammography Quality Standards Act (MQSA) guidelines, healthcare facilities that perform mammograms must now counsel patients about supplemental imaging options when dense breast
tissue is detected.
⚠️When mammography may miss up to 50% of cancers in women with heterogeneously dense breasts (and 60% of cancers in extremely dense breasts!) mammography alone just isn’t enough.
Unlock the full potential of your women’s health program with SoftVue: https://t.co/burSuEdrRf.
🎉 Happy New Year from Delphinus! As we step into 2025, we’re more committed than ever to advancing breast cancer detection and closing the care gap for women with dense breasts.
#DenseBreastAwareness#EarlyDetection
The fight for equitable access to life-saving breast imaging is on! AdvaMed is advocating for Medicare coverage of supplemental breast imaging, crucial for women with dense breast tissue. This could be a game-changer for women’s health.
Read more:https://t.co/4sFelBct5U
Dr. Saravanan from ARA joined KEYE News to discuss how SoftVue™ when combined with screening mammography, is improving breast cancer detection for women with dense breasts. Watch the full segment!
https://t.co/eWhU2BJVQq
#BreastCancer#SoftVue#WomensHealth#EarlyDetection
Jenna Fischer discussed dense breasts on The Today Show, stressing the need for better screening. SoftVue™ technology improves detection for women with dense tissue.
Watch her interview here: https://t.co/NhHrmZmScn
#JennaFischer#DenseBreasts#SoftVue#WomensHealth
On March 10th, 2023 the FDA issued a national requirement for dense breast reporting to ALL patients and their referring providers. 🎉
From previously only 38 states notifying a patient of their dense breast tissue, to all 50 within the next year!
#densebreast#womenshealth
Thank you Trinity Capital Inc for joining our journey to bring innovative life-saving medical imaging to women with dense breasts throughout the U.S.
https://t.co/28AvAA0i6E
Back to school: Delphinus Edition! 💗
Each week we will quiz you on your knowledge of breast health! 📃
Upon receiving your mammogram are all states legally required to inform you of your dense breast tissue?
Answer the poll below! 👇 #womenshealth
Great question! 💡This soft anatomically-formed guide engages with the front of the breast to center, shape and steady it during the imaging procedure. 💗
Excited to learn more? 👇
https://t.co/jhgPOKiqkr
#delphinusMT#densebreast#softvue#breastimaging#breastcancer
What are things you want to be 50% sure on? Nothing right?
Studies found that ultrasound coupled with mammography increased cancer detection rates from 48% to 97% in women with dense breast tissue. 👏
I think we can all agree we like those odds A LOT better. ✅ #breasthealth
Every woman deserves the opportunity to take charge of her health, and together, we can empower them to do just that.
Together, we can make a tangible difference in the fight against breast cancer!💕🎗️
#DelphinusCares#BreastDensityEducation#CancerAwareness#EmpowerWomen
✨ A Night To Remember! ✨ The Delphinus Medical Technology team had an incredible time this weekend at the Operation Breast Density Gala dedicated to making a real impact in women's lives. 💪
#DelphinusCares#BreastDensityEducation#CancerAwareness